Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Mycoses 3Leukemia, Myeloid, Acute 3Neutropenia 2Leukemia 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Sezary Syndrome 1Seminoma 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Neuroblastoma 1Neoplasms 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Cytarabine 13Daunorubicin 11Etoposide 7Filgrastim 5Peripheral Blood Stem Cell Transplantation 4Gemtuzumab 4valspodar 3Observation 3Mitoxantrone 3Busulfan 3sargramostim 2fludarabine phosphate 2aldesleukin 2Tretinoin 2Therapeutics 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Early Intervention, Educational 2Cyclophosphamide 2zosuquidar trihydrochloride 1midostaurin 1merphos 1laromustine 1etoposide phosphate 1dexamethasone acetate 1Whole-Body Irradiation 1Watchful Waiting 1Thioguanine 1Tacrolimus 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Congenital Abnormalities × Caspofungin × Clear all
NCT01288378 2023-12-11

Empirical Versus Preemptive Antifungal Therapy

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
556 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Mycoses, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡